Winston Kung
Board Member
Janux Therapeutics, Inc. (JANX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Winston Kung
Winston Kung is recorded as Board Member at Janux Therapeutics, Inc. (JANX). Janux Therapeutics, Inc. reported in an 8-K filed September 22, 2022 that Winston Kung was appointed Class I director, effective September 21, 2022.
“On September 21, 2022, the Board of Directors (the "Board") of Janux Therapeutics, Inc. (the "Company"), upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the "Nominating and Governance Committee"), appointed Winston Kung as a Class I director of the Company, with a term of office expiring at the Company's 2025 annual meeting of stockholders, or until his earlier death, resignation or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-09-21–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Janux Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- David Campbell CEO, Board Member
- Ron Barrett, Ph.D. Chairman
- Tighe Reardon CFO
- Alana McNulty Board Member
- Eric Dobmeier Board Member
- Natasha Hernday Board Member
- Ronald Barrett, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.